Effects of parenteral morphine and oral methadone on self-stimulation in the rat
- PMID: 7058216
- DOI: 10.1016/0091-3057(82)90017-x
Effects of parenteral morphine and oral methadone on self-stimulation in the rat
Abstract
Facilitation of self-stimulation has been reported following the administration of various opiates. Methadone, a synthetic narcotic used in the treatment of narcotic addiction, has recently been demonstrated to facilitate self-stimulation when administered parenterally. The present study examined the effects of orally administered methadone (20 and 30 mg/kg), the route of administration used clinically, on MFB-LH self-stimulation at 2.5, 5, 8, 12, 17, and 24 hours post-administration. Reliable facilitation was observed at 2.5 hours post-administration. However, the effect of methadone was less pronounced than that observed with a dose of parenteral morphine which was approximately equivalent in terms of analgesic potency.
Similar articles
-
Facilitation of self-stimulation in rats by methadone.Pharmacol Biochem Behav. 1980 Dec;13(6):919-24. doi: 10.1016/0091-3057(80)90230-0. Pharmacol Biochem Behav. 1980. PMID: 7208554
-
Dose- and time-dependent effects of narcotic analgesics on intracranial self-stimulation in the rat.Psychopharmacology (Berl). 1977 Aug 16;53(3):227-34. doi: 10.1007/BF00492356. Psychopharmacology (Berl). 1977. PMID: 19804
-
Effects of morphine and methadone treatments on glutamatergic transmission in rat frontal cortex.Pharmacol Rep. 2009 Nov-Dec;61(6):1192-7. doi: 10.1016/s1734-1140(09)70183-5. Pharmacol Rep. 2009. PMID: 20081256
-
Effects of methadone and morphine maintenance on drug-seeking behavior in the dog.Psychopharmacology (Berl). 1977 Oct 20;54(2):109-12. doi: 10.1007/BF00426764. Psychopharmacology (Berl). 1977. PMID: 412203
-
The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone.Clin Pharmacokinet. 1976;1(3):219-30. doi: 10.2165/00003088-197601030-00004. Clin Pharmacokinet. 1976. PMID: 13957 Review.
Cited by
-
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.Neuropharmacology. 2019 Nov 1;158:107609. doi: 10.1016/j.neuropharm.2019.04.015. Epub 2019 Apr 19. Neuropharmacology. 2019. PMID: 31009632 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources